Ahead of World Obesity Day, we examine the impact of the game-changing drugs that control appetite. Increasingly being taken ...

A group representing compounding pharmacies has filed a lawsuit against the US Food and Drug Administration, arguing that the ...

Scientists in China have found a new potential drug target for weight loss. Blocking a protein called CD44 has been shown to ...

Semaglutide use in patients with Type 2 diabetes was associated with reduced postoperative complications after 90 days, according to a study in the March 2025 i ...

RAs are transforming obesity treatment, demonstrating substantial weight loss and metabolic improvements with lifestyle ...

It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...

Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a ...

Outsourcing Facilities Association and North American Custom Laboratories allege the FDA removed semaglutide from its ...

People with a high body weight living in England can now access subsidised weight-loss drugs to treat their obesity.

The FDA declared the shortage of Novo Nordisk's weight-loss drugs over, giving compounders until May to stop making alternatives. An industry group representing compounders is suing. Dr. Angela Fitch ...

New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...

Cratos Health Calculated is a medical spa and wellness center in Colorado Springs specializing in weight loss, hormone ...